Merck and Institute for Systems Biology collaborate to define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers
| | | |

Merck and Institute for Systems Biology collaborate to define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers

On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…